Cargando…

Dual Negativity of CD56 and CD117 Links to Unfavorable Cytogenetic Abnormalities and Predicts Poor Prognosis in Multiple Myeloma

The prognostic value of CD56 and CD117 expression on myeloma cells is controversial. This study aims to analyze the correlation of CD56 and CD117 expression with cytogenetic abnormalities and survival. A total of 128 patients with newly diagnosed multiple myeloma (NDMM) were recruited in this single...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Dong, Zhu, Mingxia, Li, Qihui, Wan, Wenli, Chen, Yingtong, Jing, Hongmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653854/ https://www.ncbi.nlm.nih.gov/pubmed/36362752 http://dx.doi.org/10.3390/jcm11216524

Ejemplares similares

The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients
por: Ceran, Funda, et al.
Publicado: (2017)

Expression of CD81 and CD117 in plasma cell myeloma and the relationship to prognosis
por: Chen, Fang, et al.
Publicado: (2018)

PB1951: INVESTIGATION OF THE RELATIONSHIP BETWEEN CD56 AND CD117 EXPRESSIONS AND CLINICAL AND LABORATORY FINDINGS IN MULTIPLE MYELOMA PATIENTS AT DIAGNOSIS
por: Akkurd, D. M., et al.
Publicado: (2022)

To be or not to be: the role of CD56 in multiple myeloma
por: Cottini, Francesca, et al.
Publicado: (2023)

The diagnostic power of CD117, CD13, CD56, CD64, and MPO in rapid screening acute promyelocytic leukemia
por: Tran, Vinh Thanh, et al.
Publicado: (2020)

t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs
por: Narita, T, et al.
Publicado: (2015)

The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia
por: Alegretti, Ana Paula, et al.
Publicado: (2011)

The expression of the CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia
por: Rego, Eduardo Magalhães
Publicado: (2011)

Multiples aberrant phenotypes in multiple myeloma patient expressing CD56(-), CD28(+),CD19(+)
por: Leite, Luiz Arthur Calheiros, et al.
Publicado: (2012)

Role of CD135/CD117 on Prognosis and Overall Survival of Acute Myeloid Leukemia
por: Raeisi, Mortaza, et al.
Publicado: (2019)

CD117 Expression in Fibroblasts-Like Stromal Cells Indicates Unfavorable Clinical Outcomes in Ovarian Carcinoma Patients
por: Huang, Ruixia, et al.
Publicado: (2014)

NK cells CD56(bright) and CD56(dim) subset cytokine loss and exhaustion is associated with impaired survival in myeloma
por: Seymour, Frances, et al.
Publicado: (2022)

Formation of $^{117}In-H$ pairs after annealing of GaN implanted with $^{117}Cd(^{117}In)$
por: Dietrich, M, et al.
Publicado: (2001)

Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells
por: Jeong, Tae-Dong, et al.
Publicado: (2012)

Alterations in the CD56(−) and CD56(+) T Cell Subsets during COVID-19
por: Vavilova, Julia D., et al.
Publicado: (2023)

Integration of CD34(+)CD117(dim) population signature improves the prognosis prediction of acute myeloid leukemia
por: Li, Xue-Ping, et al.
Publicado: (2022)

Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts
por: Ono, Takaaki, et al.
Publicado: (2014)

Correlation between CD117+ myeloma plasma cells and hematopoietic progenitor cells in different categories of patients
por: Pojero, Fanny, et al.
Publicado: (2015)

Cytogenetic abnormality in patients with multiple myeloma analyzed by fluorescent in situ hybridization
por: Hu, Ying, et al.
Publicado: (2016)

Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response
por: Abdallah, Nadine, et al.
Publicado: (2020)

Role of CD138, CD56, and light chain immunohistochemistry in suspected and diagnosed plasma cell myeloma: A prospective study
por: Dass, Jasmita, et al.
Publicado: (2019)

CD19( (+)) CD56( (–)) myeloma arising in a patient who failed two courses of immunosupressive therapy for aplastic anaemia
por: Murray, Nigel P, et al.
Publicado: (2017)

Correlation of CD47 Expression with Adverse Clinicopathologic Features and an Unfavorable Prognosis in Colorectal Adenocarcinoma
por: Kim, Hyunsung, et al.
Publicado: (2021)

Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: evidence from meta-analysis
por: Yang, Bikang, et al.
Publicado: (2017)

PB2027: EFFICACY OF THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME WITH UNFAVORABLE IMMUNOPHENOTYPIC AND CYTOGENETIC PROGNOSIS.
por: Trubkina, Hanna, et al.
Publicado: (2023)

Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2020)

Diagnostic Challenges of CD4(+)/CD56(+)/CD123(+) hematological neoplasms
por: Thiago, Leandro S., et al.
Publicado: (2013)

High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia
por: Plesa, Adriana, et al.
Publicado: (2017)

Key Role of the CD56(low)CD16(low) Natural Killer Cell Subset in the Recognition and Killing of Multiple Myeloma Cells
por: Vulpis, Elisabetta, et al.
Publicado: (2018)

The DC-SIGN-CD56 interaction inhibits the anti-dendritic cell cytotoxicity of CD56 expressing cells
por: Nabatov, Alexey A., et al.
Publicado: (2015)

Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells
por: Schwane, Vera, et al.
Publicado: (2020)

Cytogenetic Abnormalities in Multiple Myeloma Patients at a Tertiary Healthcare Center in India
por: Govindasamy, Perumal, et al.
Publicado: (2019)

Immunoexpression of CD34, CD117, and p53 in Hypocellular Bone Marrow Disorders
por: Sharma, Pooja, et al.
Publicado: (2021)

High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia
por: Song, Ying, et al.
Publicado: (2019)

CD56(dim)CD16(high) and CD56(bright)CD16(−) cell percentages associated with maximum knee extensor strength and incidence of death in elderly
por: Senpuku, Hidenobu, et al.
Publicado: (2016)

A case of a Young Multiple Myeloma Patient With Poor Prognostic Cytogenetics
por: Iranijam, Effat, et al.
Publicado: (2023)

KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection
por: Caduff, Nicole, et al.
Publicado: (2021)

CD73 is associated with poor prognosis in HNSCC
por: Ren, Zhen-Hu, et al.
Publicado: (2016)

Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma
por: Dong, Chuanpeng, et al.
Publicado: (2021)

What is CD4+CD56+ malignancy and how should it be treated?
por: Reimer, P, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_3jth473u7pfs5l64hdprmi3pg2